spironolactone

Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.

spi·ro·no·lac·tone

(spī′rə-nō-lăk′tōn, spī-rō′-, spī-rŏn′ə-)

An aldosterone antagonist and antiandrogen, C₂₄H₃₂O₄S, that promotes diuresis and is used to treat fluid retention, androgenic syndromes in women, and hypertension.

[Alteration of spirolactone : Latin spīra, coil; see spiral + lactone.]

spironolactone

(ˌspaɪrənəʊˈlæktəʊn)

(Pharmacology) a diuretic that increases water loss from the kidneys and is much used to treat oedema in heart and kidney failure

[C20: from spiro-² + linking syllable -no- + lactone]

ThesaurusAntonymsRelated WordsSynonymsLegend:

Switch to new thesaurus

Noun

spironolactone - a synthetic corticosteroid (trade name Aldactone) used to treat hypertension

Aldactone

antihypertensive, antihypertensive drug - a drug that reduces high blood pressure

adrenal cortical steroid, corticoid, corticosteroid - a steroid hormone produced by the adrenal cortex or synthesized; administered as drugs they reduce swelling and decrease the body's immune response; "adrenal cortical steroids are used to treat many different conditions"

Translations

spironolactone

n espironolactona

Mentioned in ?

References in periodicals archive ?

Limited Tenders are invited for Supply of Tab Hydrochlor thiazide 25mg Tab Spironolactone 25 mg

Supply Of Tab Hydrochlor Thiazide 25mg Tab Spironolactone 25 Mg

The number of courses of spironolactone prescribed for acne per 100 female patients treated by dermatologists increased by 291% during the study period, from 2.

Clinicians persist in prescribing antibiotics for acne

Spironolactone use "remains relatively uncommon" compared with oral antibiotics, the researchers pointed out, noting that the 2013 data show that, for every course of spironolactone, there were 2.

Clinicians persist in prescribing oral antibiotics

The approval marks the first and only FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone.

CMP Pharma's new drug application (NDA) for CaroSpir (spironolactone) oral suspension, 25 mg/5mL was granted final approval by the FDA

Patients were categorized according to possible etiology into four groups; (1) chronic renal failure (CRF), (2) acute renal failure (ARF), and (3) angiotensin-converting-enzyme inhibito /angiotensin receptor bloker (ACEI/ARB) use, and (4) spironolactone use.

Importance of etiologic factors and electrocardiographic findings for diagnosis of emergency hyperkalemic patients

M2 EQUITYBITES-August 8, 2017-CMP Pharma awarded US FDA approval for Spironolactone Oral Suspension in 25 mg/5 ml

CMP Pharma awarded US FDA approval for Spironolactone Oral Suspension in 25 mg/5 ml

M2 PHARMA-August 8, 2017-CMP Pharma awarded US FDA approval for Spironolactone Oral Suspension in 25 mg/5 ml

CMP Pharma awarded US FDA approval for Spironolactone Oral Suspension in 25 mg/5 ml

I have been using Beyaz and Yaz for several years in my PCOS patients for the lower androgenic activity of the drospirenone based on the same assumption and its similarity to spironolactone.

Metformin and progesterone for PCOS-related infertility

WAILEA, HAWAII--While spironolactone is an old drug, it remains a safe and effective treatment option for management of acne in women, according to Julie Harper, MD, of the University of Alabama at Birmingham, speaking at the SDEF Hawaii Dermatology Seminar.

Spironolactone holds its own for treating women's acne

When a triple regimen of an ACE inhibitor or ARB, calcium channel blocker, and a thiazide diuretic fails to achieve the target blood pressure, try adding spironolactone.

Resistant hypertension? Time to consider this fourth-line drug: for most adults with resistant hypertension, spironolactone is superior to doxazosin and bisoprolol as an adjunct to triple therapy

The interaction between galectin-3, [beta]-blockers, renin-angiotensin system (RAS) blockade, and spironolactone on outcome was evaluated in TIME-CHF and validated in GISSI-HF.

Interaction of galectin-3 concentrations with the treatment effects of [beta]-blockers and RAS blockade in patients with systolic heart failure: a derivation-validation study from TIME-CHF and GISSI-HF